"An Observational Clinical Study to Evaluate COVID-19 Symptoms in Long Hauler Patients Who Participated in K031-120 or K032-120"

CompletedOBSERVATIONAL
Enrollment

333

Participants

Timeline

Start Date

March 25, 2021

Primary Completion Date

May 28, 2021

Study Completion Date

May 28, 2021

Conditions
COVID-19
Interventions
OTHER

KB109 + Self Supportive Care

KB109 is a novel glycan

OTHER

Self Supportive Care (SSC) Alone

Self Supportive Care (SSC) Alone

Trial Locations (2)

60643

Quad Clinical Research, Chicago

71913

HealthStar Research, LLC, Hot Springs

Sponsors
All Listed Sponsors
lead

Kaleido Biosciences

INDUSTRY